Funding Round attributes
Exakt Health, a health tech startup focused on digital sports physiotherapy, has raised €2 million in seed funding. The round was led by Barmenia Next Strategies (BNS) alongside other investors such as ESB Invest, Backbone Ventures, Auxxo, and several business angels. Exakt Health’s AI-powered digital physiotherapy platform, which is the first of its kind to be certified as a medical device in Germany, offers personalized recovery and injury prevention plans for athletes. The funding will be used to scale the platform, expand its user base, and conduct clinical trials to further validate its effectiveness.
Founded to address the rising demand for personalized physiotherapy solutions, Exakt Health’s platform provides tailored treatment and rehabilitation plans that adapt to individual users’ progress and needs. By leveraging artificial intelligence, the platform offers an accessible and convenient alternative to in-person physiotherapy, making it easier for athletes to receive high-quality care from the comfort of their homes.
The certification of Exakt Health’s platform as a medical device represents a significant milestone in the company's development. This recognition ensures that the platform meets rigorous safety and efficacy standards, positioning Exakt Health as a leader in digital health innovations within Germany and across Europe.
The fresh capital injection will also allow Exakt Health to enhance its offerings by refining the AI algorithms that power its personalized treatment plans. The company plans to invest in clinical studies to further validate the platform's effectiveness, as well as to expand its user base in Europe. This includes strengthening partnerships with healthcare providers and insurers to integrate the platform into broader healthcare systems.
Exakt Health’s CEO expressed excitement about the funding, noting that the support from experienced investors will accelerate the company’s growth and enable more people to benefit from accessible, effective physiotherapy. The CEO emphasized that the company is committed to making injury prevention and rehabilitation more available to athletes and active individuals, ensuring that they have the tools needed to recover quickly and safely.
The lead investor, Barmenia Next Strategies, sees strong potential in Exakt Health’s approach, particularly given the increasing demand for digital health solutions and the growing importance of preventive healthcare. Their backing, along with contributions from other investors, is expected to help Exakt Health scale rapidly and reach new markets across Europe.
In summary, Exakt Health’s €2 million seed funding will play a crucial role in scaling its digital physiotherapy platform, which is a first-of-its-kind solution certified as a medical device in Germany. The funding will help the company expand its user base, conduct clinical trials to validate its technology, and further refine its AI-powered treatment plans.
